Related Experiment Video
Updated: Jul 16, 2025

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
A dual-role for IL-10: From leukemogenesis to the tumor progression in acute lymphoblastic leukemia
Flavio Souza Silva1, Amanda Barros-Lima1, Mateus Souza-Barros1
1Programa de Pós-Graduação em Imunologia Básica e Aplicada, Instituto de Ciências Biológicas, Universidade Federal do Amazonas (UFAM), Manaus, Brazil; Diretoria de Ensino e Pesquisa, Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas (HEMOAM), Manaus, Brazil.
Insights
Interleukin-10 (IL-10) plays a dual role in childhood acute lymphoblastic leukemia (ALL), influencing its development and progression. This review explores IL-10
Area of Science:
- Immunology
- Pediatric Oncology
- Molecular Biology
Background:
- Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer.
- Children with ALL often have a deregulated immune response and environmental exposures contributing to disease onset.
- Interleukin-10 (IL-10) is a key cytokine in immune response regulation.
Purpose of the Study:
- To explore the dual role of IL-10 in the development and progression of ALL.
- To describe the biological characteristics, immunological mechanisms, genetics, and clinical implications of IL-10 in ALL.
Main Methods:
- This is a review article, synthesizing existing literature on IL-10 and ALL.
- Analysis of biological characteristics, immunological mechanisms, and genetics of IL-10.
- Evaluation of IL-10's impact on the leukemia microenvironment and clinical implications.
Main Results:
- IL-10 acts as a paradoxical mediator in ALL.
- IL-10 influences ALL development by regulating inflammatory processes.
- Increased IL-10 in the leukemia microenvironment promotes malignancy progression.
Conclusions:
- IL-10 plays a critical and complex role throughout the natural history of ALL.
- Understanding IL-10's dual function is crucial for its clinical implications in pediatric ALL.
Abstract:
Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer in the world, and accounts for 25% of all childhood cancers among children under 15 years of age. Longitudinal studies have shown that children with ALL are born with a deregulated immune response that, together with postnatal environmental exposures, favor the onset of the disease. In this context, IL-10, a key cytokine in the regulation of the immune response, presents itself as a paradoxical mediator, initially influencing the development of ALL through the regulation of inflammatory processes and later on the progression of malignancy, with the increase of this molecule in the leukemia microenvironment. According to the literature, this cytokine plays a critical role in the natural history of the disease and plays an important role in two different though complex scenarios. Thus, in this review, we explore the dual role of IL-10 in ALL, and describe its biological characteristics, immunological mechanisms and genetics, as well as its impact on the leukemia microenvironment and its clinical implications.
More Related Videos
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Lineage Commitment
Differentiation of Common Myeloid Progenitor Cells
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Abnormal Proliferation

